US Covid vaccine for children under 5 delayed by at least 2 months

On Friday, the agency said it had reviewed new trial information that arrived after Pfizer and BioNTech’s request for emergency authorization and decided it needed more data before weighing in on the authorization.

A US decision on Pfizer and BioNTech’s Covid-19 vaccine for infants and children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration (FDA) said it needed more data.